Urology Doctors in Manchester, NH Accepting Medicare

9 Urology doctors found. Showing 1 - 9

Dr. Jason Akerman, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 100 Hitchcock Way, Manchester, NH 03104 Phone: 603-629-8222

Dr. Samuel T Snipes, M.D, Urology Medicare: Accepting Medicare Assignments Practice Location: 4 Elliot Way, Suite 200, Manchester, NH 03103 Phone: 603-669-9200    Fax: 603-624-2210

John Jason Munoz, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 4 Elliot Way, Suite 200, Manchester, NH 03103 Phone: 603-669-9200    Fax: 603-624-2210

William Albert Selleck, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 4 Elliot Way, Suite 200, Manchester, NH 03103 Phone: 603-669-9200    Fax: 603-624-2210

Sarah Mcaleer, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 4 Elliot Way, Suite 200, Manchester, NH 03103 Phone: 603-669-9200    Fax: 603-624-2210

Dr. Armando E Lopez, M.D. Urology Medicare: Medicare Enrolled Practice Location: 718 Smyth Rd Fl 3, Manchester, NH 03104 Phone: 603-624-4366

Ishwar Chander Chopra, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 88 Mcgregor St, Ste 305, Manchester, NH 03102 Phone: 603-622-2007    Fax: 603-622-9538

Dr. Cyrus B Noble, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 4 Elliot Way Ste 200, Manchester, NH 03103 Phone: 603-669-9200    Fax: 603-669-9286

Christopher Girasole, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 4 Elliot Way, Suite 200, Manchester, NH 03103 Phone: 603-669-9200    Fax: 603-624-2210

News Archive

Exposure to carcinogens called arylamines is associated with bladder cancer risk in both smokers and nonsmokers

Exposure to a family of carcinogens called arylamines is associated with bladder cancer risk in both smokers and nonsmokers, according to a new study in the October 6 issue of the Journal of the National Cancer Institute.

Researchers design molecules that can stop colon cancer progression

A Basque research consortium has managed to halt the progress of colon cancer and its metastasis in the liver in an experimental model with mice. This advance, that may open a new path for the future treatment of such pathologies, has been achieved by creating molecules which interfere with the adhesion of tumour cells to other cells of the organism. In this way, the molecules halt both the growth of the tumour and the dissemination of the tumour to and its proliferation in other organs.

Gleevec's uses might expand even further

Gleevec (Imatinib) is a representative of the newest generation of cancer drugs. The substance conveys its potent anti-proliferative effect by selectively supressing the tyrosine kinase pathway. The Giessen lung researchers now issue a first report of this substance as a new target therapy for pulmonary hypertension

CRT teams up with The University of Auckland to discover novel treatments for cancer

Cancer Research Technology - Cancer Research UK's development and commercialisation arm has teamed up with The University of Auckland to advance the discovery of new molecular targeted compounds for the treatment of leukaemia.

Study confirms Artelon Cosmetic can treat patients with tissue defects

A post-market study has been conducted by the Brånemark Clinic in Gothenburg on Artelon Cosmetic for soft tissue augmentation in the upper jaw. The study confirms that patients with tissue defects can be treated successfully with Artelon Cosmetic.

Read more Medical News

› Verified 9 days ago